Mabs | www.gmachineinfo.com | 全球机械文献资源网

OA期刊

ISSN	1942-0862
刊名	Mabs
出版商	Taylor & Francis Inc.
url	https://www.tandfonline.com/loi/kmab20
机构	Taylor & Francis Ltd.

全部

2010	2011	2012	2013	2014	2015
2016	2017	2018	2019	2020	2021
2022	2023	2024	2025

2016, vol.8, no.1	2016, vol.8, no.2	2016, vol.8, no.3	2016, vol.8, no.4	2016, vol.8, no.5	2016, vol.8, no.6
2016, vol.8, no.7	2016, vol.8, no.8

题名

作者

出版年

年卷期

Microscale screening of antibody libraries as maytansinoid antibody-drug conjugates

Kalli C. Catcott;Molly A. McShea;Carl Uli Bialucha;Kathy L. Miller;Stuart W. Hicks;Parmita Saxena;Thomas G. Gesner;Mikias Woldegiorgis;Megan E. Lewis;Chen Bai;Michael S. Fleming;Seth A. Ettenberg;Hans K. Erickson;Nicholas C. Yoder;

2016

2016, vol.8, no.3

Combining phage display with de novo protein sequencing for reverse engineering of monoclonal antibodies

Keith W. Rickert;Luba Grinberg;Robert M. Woods;Susan Wilson;Michael A. Bowen;Manuel Baca;

2016

2016, vol.8, no.3

Pregnancy-specific glycoprotein expression in normal gastrointestinal tract and in tumors detected with novel monoclonal antibodies

Aileen Houston;John M. Williams;Tihana Lenac Rovis;Daniel K. Shanley;Ronan T. O'Riordan;Patrick A. Kiely;Melanie Ball;Orla P. Barry;Jacquie Kelly;Aine Fanning;John MacSharry;Ofer Mandelboim;Bernhard B. Singer;Stipan Jonjic;Tom Moore;

2016

2016, vol.8, no.3

Immunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells

Maria-Luisa del Rio;Carlos Fernandez-Renedo;Olivier Chaloin;Stefanie Scheu;Klaus Pfeffer;Yasushi Shintani;Jose-Antonio Perez-Simon;Pascal Schneider;Jose-Ignacio Rodriguez-Barbosa;

2016

2016, vol.8, no.3

Inhibition of CD73 AMP hydrolysis by a therapeutic antibody with a dual, non-competitive mechanism of action

James C. Geoghegan;Gundo Diedrich;Xiaojun Lu;Kim Rosenthal;Kris F. Sachsenmeier;Herren Wu;William F. Dall'Acqua;Melissa M. Damschroder;

2016

2016, vol.8, no.3

CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors

Con Panousis;Urmi Dhagat;Kirsten M. Edwards;Veronika Rayzman;Matthew P. Hardy;Hal Braley;Gail M. Gauvreau;Timothy R. Hercus;Steven Smith;Roma Sehmi;Laura McMillan;Mara Dottore;Barbara J. McClure;Louis J. Fabri;Gino Vairo;Angel F Lopez;Michael W. Parker;Andrew D. Nash;Nicholas J. Wilson;Michael J. Wilson;Catherine M. Owczarek;

2016

2016, vol.8, no.3

Note of appreciation to reviewers

Janice M. Reichert;

2016

2016, vol.8, no.3

Antibody engineering therapeutics, the annual meeting of the antibody society December 7–10, 2015, San Diego, CA, USA

Matthias Pauthner;Jenny Yeung;Chris Ullman;Joost Bakker;Thierry Wurch;Janice M. Reichert;Fridtjof Lund-Johansen;Andrew R.M. Bradbury;Paul J. Carter;Joost P.M. Melis;

2016

2016, vol.8, no.3

Waiving in vivo studies for monoclonal antibody biosimilar development: National and global challenges

Kathryn Chapman;Akosua Adjei;Paul Baldrick;Antonio da Silva;Karen De Smet;Richard DiCicco;Seung Suh Hong;David Jones;Michael W. Leach;James McBlane;Ian Ragan;Praveen Reddy;Donald I. H. Stewart;Amanda Suitters;Jennifer Sims;

2016

2016, vol.8, no.3

Pharmacokinetics and pharmacodynamics of ch14.18/CHO in relapsed/refractory high-risk neuroblastoma patients treated by long-term infusion in combination with IL-2

Nikolai Siebert;Christin Eger;Diana Seidel;Madlen Jüttner;Maxi Zumpe;Danilo Wegner;Silke Kietz;Karoline Ehlert;Gareth J. Veal;Werner Siegmund;Michael Weiss;Hans Loibner;Ruth Ladenstein;Holger N. Lode;

2016

2016, vol.8, no.3